✉news ScienceBiology first seen 15 h ago, last 32 min ago, peak #4
Insitro and AstraZeneca Partner on AI Drug Discovery
Original: insitro Announces a Strategic Collaboration with AstraZeneca for AI-enabled Discovery of Novel Therapeutics for MASH and Cardiomyopathies
Biotech company insitro announced a strategic collaboration with AstraZeneca to use artificial intelligence and machine learning to discover novel therapeutics for MASH, a liver disease, and cardiomyopathies. The deal pairs insitro's data-driven drug discovery platform with AstraZeneca's development capabilities. The announcement was covered by industry outlets and is drawing attention within the biotech and pharmaceutical sectors.
Why now: Major pharma partnering with an AI drug discovery startup signals growing industry adoption of machine learning in drug development.
insitroAstraZenecaMASHcardiomyopathies
Rank over time, top of the chart is #1. 12 snapshots from 15 h ago to 32 min ago.
Evidence
API: https://socialmediatrends-api.osmike.com/v1/trends/2356387